Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
Chest
|
May 20, 2019
Differences in COPD Exacerbation Risk Between Women and Men: Analysis From the UK Clinical Practice Research Datalink Data
Daiana Stolz, Konstantinos Kostikas, Emil Loefroth, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
February 9, 2017
Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study
Jadwiga A Wedzicha, Nanshan Zhong, Masakazu Ichinose, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
December 24, 2016
Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis
Claus Vogelmeier, Nanshan Zhong, Michael J Humphries, et al.
Academic Radiology
|
September 16, 2008
Hyperpolarized 3He magnetic resonance imaging of chronic obstructive pulmonary disease: reproducibility at 3.0 tesla
Lindsay Mathew, Andrea Evans, Alexei Ouriadov, et al.
Respiratory Medicine
|
August 20, 2014
Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients
Jadwiga A Wedzicha, Ronald Dahl, Roland Buhl, et al.
Sleep
|
November 10, 2004
Postural effects on pharyngeal protective reflex mechanisms
Atul Malhotra, John Trinder, Robert Fogel, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
August 9, 2020
Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database
Konstantinos Kostikas, David Price, Florian S Gutzwiller, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
April 1, 2017
LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
Gustavo J Rodrigo, David Price, Antonio Anzueto, et al.
Nature Reviews. Drug Discovery
|
May 23, 2015
Drug development for airway diseases: looking forward
Stephen Holgate, Alvar Agusti, Robert M Strieter, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
May 13, 2017
The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD
Antonio R Anzueto, Claus F Vogelmeier, Konstantinos Kostikas, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
Chest
|
May 20, 2019
Differences in COPD Exacerbation Risk Between Women and Men: Analysis From the UK Clinical Practice Research Datalink Data
Daiana Stolz, Konstantinos Kostikas, Emil Loefroth, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
February 9, 2017
Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study
Jadwiga A Wedzicha, Nanshan Zhong, Masakazu Ichinose, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
December 24, 2016
Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis
Claus Vogelmeier, Nanshan Zhong, Michael J Humphries, et al.
Academic Radiology
|
September 16, 2008
Hyperpolarized 3He magnetic resonance imaging of chronic obstructive pulmonary disease: reproducibility at 3.0 tesla
Lindsay Mathew, Andrea Evans, Alexei Ouriadov, et al.
Respiratory Medicine
|
August 20, 2014
Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in COPD patients
Jadwiga A Wedzicha, Ronald Dahl, Roland Buhl, et al.
Sleep
|
November 10, 2004
Postural effects on pharyngeal protective reflex mechanisms
Atul Malhotra, John Trinder, Robert Fogel, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
August 9, 2020
Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database
Konstantinos Kostikas, David Price, Florian S Gutzwiller, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
April 1, 2017
LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
Gustavo J Rodrigo, David Price, Antonio Anzueto, et al.
Nature Reviews. Drug Discovery
|
May 23, 2015
Drug development for airway diseases: looking forward
Stephen Holgate, Alvar Agusti, Robert M Strieter, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
May 13, 2017
The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD
Antonio R Anzueto, Claus F Vogelmeier, Konstantinos Kostikas, et al.
Page
of 4